Company Filing History:
3 out of 91 
2 out of 26 
1 out of 2 Years Active: 2012-2020
Title: Matt S Melvin: A Pioneer in Nicotinic Receptor Research
Introduction
Matt S Melvin, an accomplished inventor based in Winston-Salem, NC, has made significant contributions to the field of pharmacology with a total of six patents to his name. His innovations primarily focus on the modulation of nicotinic receptors, playing a crucial role in advancing medical therapies.
Latest Patents
One of Matt's latest patents involves nicotinic receptor non-competitive antagonists. This invention pertains to compounds that modulate nicotinic receptors as non-competitive antagonists, detailing the methods for their use and the pharmaceutical compositions related to these compounds. Furthermore, he has developed additional patents on similar compounds, also focusing on their synthesis and therapeutic applications.
Career Highlights
Throughout his career, Matt has worked with noteworthy companies such as Targacept, Inc. and Catalyst Biosciences, Inc. His tenure at these organizations provided him with the platform to develop and refine his innovative ideas, contributing to advancements in pharmacological treatments.
Collaborations
Collaboration has been key to Matt's success as an inventor. He has worked alongside esteemed colleagues, including Yunde Xiao and Srinivasa Rao Akireddy, fostering a dynamic environment conducive to innovation and discovery in their field.
Conclusion
Matt S Melvin's work exemplifies the intersection of scientific research and practical applications in medicine. With his patents focusing on nicotinic receptors, he continues to play an integral role in shaping pharmaceutical advancements. His contributions not only reflect his expertise but also the collaborative spirit within the scientific community.